Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use

US6498156B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Heiner Glombik · Hofheim, DE
• Werner Kramer · Schwandorf, DE
• Stefanie Flohr · Basel, CH
• Wendelin Frick · Bad Camberg, DE
• Hubert Heuer · Frankfurt am Main, DE
• Gerhard Jaehne · Frankfurt, DE
• Andreas Lindenschmidt · Bad Soden, DE
• Hans-Ludwig Schaefer · Frankfurt am Main, DE

Key dates

• Filing date: Dec 19, 2001
• Grant date: Dec 24, 2002
• Expiry date: Dec 19, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula I, in which R1, R2, R3, R4, R5, and R6 have the meanings given in the description, and their physiologically acceptable salts. The compounds are suitable for use, for example, as hypolipidemics.